Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility

References

• Alonzo DE, Zhang GG, Zhou D, Gao Y, Taylor LS. (2010). Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res, 27, 608–618.
   PubMed Web of Science ®Google Scholar
• Alsenz J, Meister E, Haenel E. (2007). Development of a partially automated solubility screening (PASS) assay for early drug development. J Pharm Sci, 96, 1748–1762.
   PubMed Web of Science ®Google Scholar
• Appel LE, Babcock WC, Friesen DT, Ray RJ, Shamblin SL, Shanker RM, Smithey DT. (2006). Pharmaceutical dosage forms comprising a low-solubility drug and a polymer. US Patent WO/2006/024944. March 9.
   Google Scholar
• Bakatselou V, Oppenheim RC, Dressman JB. (1991). Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm Res, 8, 1461–1469.
   PubMed Web of Science ®Google Scholar
• Bansal SS, Kaushal AM, Bansal AK. (2007). Molecular and thermodynamic aspects of solubility advantage from solid dispersions. Mol Pharm, 4, 794–802.
   PubMed Web of Science ®Google Scholar
• Bodvik R, Dedinaite A, Karlson L, Bergstrom M, Baverback P, Pedersen JS, Edward K, Karlsson G, Varga I, Claesson PM. (2010). Aggregation and network formation of aqueous methylcellulose and hydroxypropylmethylcellulose solutions. Colloids Surf A-Physicochem Eng Asp, 354, 162–171.
   Web of Science ®Google Scholar
• Brewster ME, Neeskens P, Peeters J. (2007). Solubilization of itraconazole as a function of cyclodextrin structural space. J Inclusion Phenom Macrocycl Chem, 57, 561–566.
   Web of Science ®Google Scholar
• Brewster ME, Vandecruys R, Peeters J, Neeskens P, Verreck G, Loftsson T. (2008). Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions. Eur J Pharm Sci, 34, 94–103.
   PubMed Web of Science ®Google Scholar
• Brouwers J, Brewster ME, Augustijns P. (2009). Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci, 98, 2549–2572.
   PubMed Web of Science ®Google Scholar
• Chiou WL. (1977). Pharmaceutical applications of solid dispersion systems: X-ray diffraction and aqueous solubility studies on griseofulvin–polyethylene glycol 6000 systems. J Pharm Sci, 66, 989–991.
   PubMed Web of Science ®Google Scholar
• Chutimaworapan S, Ritthidej GC, Yonemochi E, Oguchi T, Yamamoto K. (2000). Effect of water-soluble carriers on dissolution characteristics of nifedipine solid dispersions. Drug Dev Ind Pharm, 26, 1141–1150.
   PubMed Web of Science ®Google Scholar
• Clarysse S, Psachoulias D, Brouwers J, Tack J, Annaert P, Duchateau G, Reppas C, Augustijns P. (2009). Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs. Pharm Res, 26, 1456–1466.
   PubMed Web of Science ®Google Scholar
• Crowley KJ, Zografi G. (2003). The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state. Pharm Res, 20, 1417–1422.
   PubMed Web of Science ®Google Scholar
• Curatolo W, Nightingale JA, Herbig SM. (2009). Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res, 26, 1419–1431.
   PubMed Web of Science ®Google Scholar
• Dai WG, Dong LC, Shi X, Nguyen J, Evans J, Xu Y, Creasey AA. (2007). Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME). J Pharm Sci, 96, 2957–2969.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Miller DA, Yang W, McGinity JW, Williams RO 3rd. (2008). Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. Mol Pharm, 5, 968–980.
   PubMed Web of Science ®Google Scholar
• Doherty WOS, Fellows CM, Gorjian S, Senogles E, Cheung WH. (2004). Inhibition of calcium oxalate monohydrate by poly(acrylic acid)s with different end groups. J Appl Polym Sci, 91, 2035–2041.
   Web of Science ®Google Scholar
• Donnet M, Aimable A, Lemaître J, Bowen P. (2010). Contribution of aggregation to the growth mechanism of seeded calcium carbonate precipitation in the presence of polyacrylic acid. J Phys Chem B, 114, 12058–12067.
   PubMed Web of Science ®Google Scholar
• Dunitz JD, Bernstein J. (1995). Disappearing polymorphs. Acc Chem Res, 28, 193–200.
   Web of Science ®Google Scholar
• Ebewele RO. (2000). Polymer Science and Technology, Boca Raton: CRC Press.
   Google Scholar
• Erlich L, Yu D, Pallister DA, Levinson RS, Gole DG, Wilkinson PA, Erlich RE, Reeve LE, Viegas TX. (1999). Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules. Int J Pharm, 179, 49–53.
   PubMed Web of Science ®Google Scholar
• Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JA. (2008). Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm, 5, 1003–1019.
   PubMed Web of Science ®Google Scholar
• Gao P, Akrami A, Alvarez F, Hu J, Li L, Ma C, Surapaneni S. (2009). Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. J Pharm Sci, 98, 516–528.
   PubMed Web of Science ®Google Scholar
• Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. (2004). Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm, 30, 221–229.
   PubMed Web of Science ®Google Scholar
• Gao P, Morozowich W. (2006). Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv, 3, 97–110.
   PubMedGoogle Scholar
• Gao P, Rush BD, Pfund WP, Huang T, Bauer JM, Morozowich W, Kuo MS, Hageman MJ. (2003). Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci, 92, 2386–2398.
   PubMed Web of Science ®Google Scholar
• Garekani HA, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR. (2000). Highly compressible paracetamol: I: crystallization and characterization. Int J Pharm, 208, 87–99.
   PubMed Web of Science ®Google Scholar
• Gift AD, Luner PE, Luedeman L, Taylor LS. (2008). Influence of Polymeric Excipients on Crystal Hydrate Formation Kinetics in Aqueous Slurries. J Pharm Sci, 97, 5198–5211.
   PubMed Web of Science ®Google Scholar
• Guo S, Zhang L, Wang Z, Liu J. (2002). [Effects of conditioned medium derived from different keratinocytes on proliferation and collagen synthesis of hypertrophic scar fibroblasts]. Zhonghua Zheng Xing Wai Ke Za Zhi, 18, 83–85.
   PubMedGoogle Scholar
• Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. (2005). Role of molecular interaction in stability of celecoxib–PVP amorphous systems. Mol Pharm, 2, 384–391.
   PubMed Web of Science ®Google Scholar
• Guzmán HR, Tawa M, Zhang Z, Ratanabanangkoon P, Shaw P, Gardner CR, Chen H, Moreau JP, Almarsson O, Remenar JF. (2007). Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. J Pharm Sci, 96, 2686–2702.
   PubMed Web of Science ®Google Scholar
• Hilton JE, Summers MP. (1986). The effect of wetting agents on the dissolution of indomethacin solid dispersion systems. Int J Pharm, 31, 157–164.
   Web of Science ®Google Scholar
• Iervolino M, Cappello B, Raghavan SL, Hadgraft J. (2001). Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int J Pharm, 212, 131–141.
   PubMed Web of Science ®Google Scholar
• Jannink G, Cloizeaux JD. (1990). Polymers in solution. J Phys: Condensed Matter, 2, 1.
   Web of Science ®Google Scholar
• Janssens S, Nagels S, Armas HN, D’Autry W, Van Schepdael A, Van den Mooter G. (2008). Formulation and characterization of ternary solid dispersions made up of itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm, 69, 158–166.
   PubMed Web of Science ®Google Scholar
• Kachrimanis K, Ktistis G, Malamataris S. (1998). Crystallisation conditions and physicomechanical properties of ibuprofen-Eudragit (R) S100 spherical crystal agglomerates prepared by the solvent-change technique. Int J Pharm, 173, 61–74.
   Web of Science ®Google Scholar
• Kachrimanis K, Malamataris S. (1999). Crystallization of paracetamol from ethanol–water solutions in the presence of polymers. J Pharm Pharmacol, 51, 1219–1227.
   PubMed Web of Science ®Google Scholar
• Kachrimanis K, Nikolakakis I, Malamataris S. (2000). Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers. J Pharm Sci, 89, 250–259.
   PubMed Web of Science ®Google Scholar
• Karavas E, Georgarakis E, Sigalas MP, Avgoustakis K, Bikiaris D. (2007). Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug–polymer interactions. Eur J Pharm Biopharm, 66, 334–347.
   PubMed Web of Science ®Google Scholar
• Karavas E, Ktistis G, Xenakis A, Georgarakis E. (2006). Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur J Pharm Biopharm, 63, 103–114.
   PubMed Web of Science ®Google Scholar
• Kashchiev D, van Rosmalen GM. (2003). Review: nucleation in solutions revisited. Crystal Res Technol, 38, 555–574.
   Web of Science ®Google Scholar
• Katzhendler I, Azoury R, Friedman M. (1998). Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose. J Control Release, 54, 69–85.
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Hirai H, Sakai K, Sera S, Nakajima T, Ebisawa Y, Koyama K. (1992). Crystallization of inorganic-compounds in polymer-solutions. 1. Control of shape and form of calcium-carbonate. Colloid Polym Sci, 270, 1176–1181.
   Web of Science ®Google Scholar
• Kim IW, Robertson RE, Zand R. (2005). Effects of some nonionic polymeric additives on the crystallization of calcium carbonate. Crystal Growth Des, 5, 513–522.
   Web of Science ®Google Scholar
• Kohri N, Yamayoshi Y, Xin H, Iseki K, Sato N, Todo S, Miyazaki K. (1999). Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J Pharm Pharmacol, 51, 159–164.
   PubMed Web of Science ®Google Scholar
• Kondo S, Sugimoto I. (1987). Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier. J Pharmacobiodyn, 10, 587–594.
   PubMedGoogle Scholar
• Konno H, Handa T, Alonzo DE, Taylor LS. (2008). Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm, 70, 493–499.
   PubMed Web of Science ®Google Scholar
• Konno H, Taylor LS. (2006). Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci, 95, 2692–2705.
   PubMed Web of Science ®Google Scholar
• Kossel W. (1934). The energetics of surface procedures. Annalen Der Physik, 413, 457–480.
   Google Scholar
• Kossena GA, Charman WN, Boyd BJ, Dunstan DE, Porter CJ. (2004). Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci, 93, 332–348.
   PubMed Web of Science ®Google Scholar
• Kostewicz ES, Wunderlich M, Brauns U, Becker R, Bock T, Dressman JB. (2004). Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J Pharm Pharmacol, 56, 43–51.
   PubMed Web of Science ®Google Scholar
• Kulak AN, Iddon P, Li Y, Armes SP, Cölfen H, Paris O, Wilson RM, Meldrum FC. (2007). Continuous structural evolution of calcium carbonate particles: a unifying model of copolymer-mediated crystallization. J Am Chem Soc, 129, 3729–3736.
   PubMed Web of Science ®Google Scholar
• Kumar S, Chawla G, Bansal AK. (2008a). Role of additives like polymers and surfactants in the crystallization of mebendazole. Yakugaku Zasshi, 128, 281–289.
   PubMed Web of Science ®Google Scholar
• Kumar S, Chawla G, Bansal AK. (2008b). Spherical crystallization of mebendazole to improve processability. Pharm Dev Technol, 13, 559–568.
   PubMed Web of Science ®Google Scholar
• Kushida I, Ichikawa M, Asakawa N. (2002). Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion. J Pharm Sci, 91, 258–266.
   PubMed Web of Science ®Google Scholar
• Lapasin R, Pricl S. (1995). Rheology of Industrial Polysaccharides: Theory and Applications. London: Blackie Academic and Profession.
   Google Scholar
• Lin S-Y Yang, J-C. (1987). Drug interactions in pharmaceutical formulations. Part VII: Solubility and thermodynamic parameters of diazepam in pluronic surfactant solutions. Acta Pharm Technol, 33, 222–224.
   Web of Science ®Google Scholar
• Lindfors L, Forssén S, Westergren J, Olsson U. (2008). Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interface Sci, 325, 404–413.
   PubMed Web of Science ®Google Scholar
• Lioliou MG, Paraskeva CA, Koutsoukos PG, Payatakes AC. (2006). Calcium sulfate precipitation in the presence of water-soluble polymers. J Colloid Interface Sci, 303, 164–170.
   PubMed Web of Science ®Google Scholar
• Liu R. (ed.) (2008). Water-Insoluble Drug Formulation. Boca Raton: CRC Press.
   Google Scholar
• Liu YL, Liu YC, Zhang JY, Lu YM, Shen DZ, Fan XW. (2006). ZnO hexagonal prisms grown onto p-Si (111) substrate from poly (vinylpyrrolidone) assisted electrochemical assembly. J Crystal Growth, 290, 405–409.
   Web of Science ®Google Scholar
• Loftsson T, Fririksdóttir H, Gumundsdóttir TK. (1996). The effect of water-soluble polymers on aqueous solubility of drugs. Int J Pharm, 127, 293–296.
   Web of Science ®Google Scholar
• Machefer S, Huddar MM, Schnitzlein K. (2008). Effect of polymer admixtures on the growth habit of ionic crystals. Study on crystal growth kinetics of potassium dihydrogen phosphate in water/polyol mixtures. J Crystal Growth, 310, 5347–5356.
   Web of Science ®Google Scholar
• Mallick S, Dey PK, Sannigrahi S, Mitra A. (2004). Crystallization of a non-steroidal anti-inflammatory drug from ethanol–water solution in presence of polymers: physicochemical characterization and release behaviour from suppositories. Acta Pol Pharm, 61, 447–453.
   PubMedGoogle Scholar
• Martinez-Cruz N, Carrillo-Romo F, Jaramillo-Vigueras D. (2004). Effect of molecular weight of polystyrensulfonic acid sodium salt polymers on the precipitation kinetics of sodium bicarbonate. J Crystal Growth, 270, 573–581.
   Web of Science ®Google Scholar
• Matteucci ME, Brettmann BK, Rogers TL, Elder EJ, Williams RO 3rd, Johnston KP. (2007). Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm, 4, 782–793.
   PubMed Web of Science ®Google Scholar
• Megrab NA, Williams AC, Barry BW. (1995). Estradiol permeation through human skin and silastic membrane—effects of propylene-glycol and supersaturation. J Control Release, 36, 277–294.
   Web of Science ®Google Scholar
• Miller DA, DiNunzio JC, Yang W, McGinity JW, Williams RO 3rd. (2008). Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Drug Dev Ind Pharm, 34, 890–902.
   PubMed Web of Science ®Google Scholar
• Mirza S, Miroshnyk I, Heinämäki J, Antikainen O, Rantanen J, Vuorela P, Vuorela H, Yliruusi J. (2009). Crystal morphology engineering of pharmaceutical solids: tabletting performance enhancement. AAPS PharmSciTech, 10, 113–119.
   PubMed Web of Science ®Google Scholar
• Mullin JW. (2001). Crystallization. Oxford: Butterworth-Heinemann.
   Google Scholar
• Munoz-Espi R, Burger C, Krishnan CV, Chu B. (2008). Polymer-controlled crystallization of molybdenum oxides from peroxomolybdates: structural diversity and application to catalytic epoxidation. Chem Mater, 20, 7301–7311.
   Web of Science ®Google Scholar
• Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK, Woo JS, Lyoo WS, Yong CS, Choi HG. (2007). Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm, 343, 228–237.
   PubMed Web of Science ®Google Scholar
• O’Driscoll KM, Corrigan OI. (1982). Chlorothiazide–polyvinylpyrrolidone (PVP) interactions: influence on membrane permeation (everted rat intestine) and dissolution. Drug Dev Ind Pharm, 8, 547–564.
   Web of Science ®Google Scholar
• Oaki Y, Imai H. (2005). Morphological evolution of inorganic crystal into zigzag and helical architectures with an exquisite association of polymer: a novel approach for morphological complexity. Langmuir, 21, 863–869.
   PubMed Web of Science ®Google Scholar
• Oner M, Dogan O, Oner G. (1998). The influence of polyelectrolytes architecture on calcium sulfate dihydrate growth retardation. J Crystal Growth, 186, 427–437.
   Web of Science ®Google Scholar
• Overhoff KA, McConville JT, Yang W, Johnston KP, Peters JI, Williams RO 3rd. (2008). Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing. Pharm Res, 25, 167–175.
   PubMed Web of Science ®Google Scholar
• Overhoff KA, Moreno A, Miller DA, Johnston KP, Williams RO 3rd. (2007). Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing. Int J Pharm, 336, 122–132.
   PubMed Web of Science ®Google Scholar
• Pellett MA, Castellano S, Hadgraft J, Davis AF. (1997a). The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J Control Release, 46, 205–214.
   Web of Science ®Google Scholar
• Pellett MA, Roberts MS, Hadgraft J. (1997b). Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm, 151, 91–98.
   Web of Science ®Google Scholar
• Perng C-Y Kearney, AS, Patel K, Palepu NR, Zuber G. (1998). Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor. Int J Pharm, 176, 31–38.
   Google Scholar
• Plaizier-Vercammen JA. (1983). Interaction of povidone with aromatic compounds IV: effects of macromolecule molecular weight, solvent dielectric constant, and ligand solubility on complex formation. J Pharm Sci, 72, 1042–1044.
   PubMed Web of Science ®Google Scholar
• Plaizier-Vercammen JA, De Nève RE. (1982). Interaction of povidone with aromatic compounds III: thermodynamics of the binding equilibria and interaction forces in buffer solutions at varying pH values and varying dielectric constant. J Pharm Sci, 71, 552–556.
   PubMed Web of Science ®Google Scholar
• Plaizier-Vercammen JA, De Nève RE. (1981). Interaction of povidone with aromatic compounds II: evaluation of ionic strength, buffer concentration, temperature, and pH by factorial analysis. J Pharm Sci, 70, 1252–1256.
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Kiepfer B, Davis AF, Kazarian SG, Hadgraft J. (2001a). Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharm, 221, 95–105.
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Schuessel K, Davis A, Hadgraft J. (2003). Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems. Int J Pharm, 261, 153–158.
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2001b). Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm, 212, 213–221.
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2000). Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm, 193, 231–237.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Hornedo N, Murphy D. (1999). Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J Pharm Sci, 88, 651–660.
   PubMed Web of Science ®Google Scholar
• Sangwal K. (2007). Additives and Crystallization Processes: From Fundamentals to Applications. Chichester: John Wiley & Sons.
   Google Scholar
• Sekikawa H, Nakano M, Arita T. (1978a). [Dissolution behaviors and gastrointestinal absorption of sulfisoxazole in sulfisoxazole–polyvinylpyrrolidone coprecipitate (author’s transl)]. Yakugaku Zasshi, 98, 62–66.
   PubMed Web of Science ®Google Scholar
• Sekikawa H, Nakano M, Arita T. (1978b). Inhibitory effect of poly(vinylpyrrolidone) on the crystallization of drugs. Chem Pharm Bull, 26, 118–126.
   Web of Science ®Google Scholar
• Simonelli AP, Mehta SC, Higuchi WI. (1976). Dissolution rates of high energy sulfathiazole–povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies. J Pharm Sci, 65, 355–361.
   PubMed Web of Science ®Google Scholar
• Smith BR, Alexander AE. (1970). The effect of additives on the process of crystallization II. Further studies on calcium sulphate (1). J Colloid Interface Sci, 34, 81–90.
   Web of Science ®Google Scholar
• Suzuki H, Sunada H. (1998a). Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem Pharm Bull, 46, 482–487.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sunada H. (1998b). Some factors influencing the dissolution of solid dispersions with nicotinamide and hydroxypropylmethylcellulose as combined carriers. Chem Pharm Bull, 46, 1015–1020.
   Web of Science ®Google Scholar
• Tanno F, Nishiyama Y, Kokubo H, Obara S. (2004). Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Dev Ind Pharm, 30, 9–17.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res, 14, 1691–1698.
   PubMed Web of Science ®Google Scholar
• Teberekidis VI, Sigalas MP. (2007). Theoretical study of hydrogen bond interactions of felodipine with polyvinylpyrrolidone and polyethyleneglycol. J Mol Struct Theochem, 803, 29–38.
   Web of Science ®Google Scholar
• Tian F, Baldursdottir S, Rantanen J. (2009). Effects of polymer additives on the crystallization of hydrates: a molecular-level modulation. Mol Pharm, 6, 202–210.
   PubMedGoogle Scholar
• Tonge SR, Tighe BJ. (2001). Responsive hydrophobically associating polymers: a review of structure and properties. Adv Drug Deliv Rev, 53, 109–122.
   PubMed Web of Science ®Google Scholar
• Usui F, Maeda K, Kusai A, Nishimura K, Keiji Y. (1997). Inhibitory effects of water-soluble polymers on precipitation of RS-8359. Int J Pharm, 154, 59–66.
   Web of Science ®Google Scholar
• Van Speybroeck M, Mols R, Mellaerts R, Thi TD, Martens JA, Van Humbeeck J, Annaert P, Van den Mooter G, Augustijns P. (2010). Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. Eur J Pharm Biopharm, 75, 354–365.
   PubMed Web of Science ®Google Scholar
• Vandecruys R, Peeters J, Verreck G, Brewster ME. (2007). Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design. Int J Pharm, 342, 168–175.
   PubMed Web of Science ®Google Scholar
• Vargeese AA, Joshi SS, Krishnamurthy VN. (2008). Role of poly(vinyl alcohol) in the crystal growth of ammonium perchlorate. Crystal Growth Des, 8, 1060–1066.
   Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today, 12, 1068–1075.
   PubMed Web of Science ®Google Scholar
• Vogt M, Kunath K, Dressman JB. (2008a). Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Eur J Pharm Biopharm, 68, 330–337.
   PubMed Web of Science ®Google Scholar
• Vogt M, Vertzoni M, Kunath K, Reppas C, Dressman JB. (2008b). Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs. Eur J Pharm Biopharm, 68, 338–345.
   PubMed Web of Science ®Google Scholar
• Wen H, Morris KR, Park K. (2005). Hydrogen bonding interactions between adsorbed polymer molecules and crystal surface of acetaminophen. J Colloid Interface Sci, 290, 325–335.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Nakate T, Okimoto K, Ohike A, Tokunaga Y, Ibuki R, Higaki K, Kimura T. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm, 267, 79–91.
   PubMed Web of Science ®Google Scholar
• Yokoi Y, Yonemochi E, Terada K. (2005). Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension. Int J Pharm, 290, 91–99.
   PubMed Web of Science ®Google Scholar
• Ziller KH, Rupprecht H. (1988). Control of crystal growth in drug suspensions: 1. Design of a control unit and application to acetaminophen suspensions. Drug Dev Ind Pharm, 14, 2341–2370.
   Web of Science ®Google Scholar